COPD is significantly underdiagnosed
Associate Professor Debbie Rigby FPS[/caption]
Nicolette Ellis MPS[/caption]
Professor John Turnidge AO[/caption]
FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
PSA launches bold five-year plan for pharmacy
A new vision for the role of pharmacists launched PSA18 in Sydney today, with the unveiling of PSA’s Pharmacists in 2023: A Discussion Paper,...
Improving medicines use in aged care
We know that there are high levels of medicines use in the aged care setting, which is not surprising given the demographics of residents and...
Government pledges to improve medicine safety in aged care
The Federal Government has committed to improving medicine safety in aged care, as part of a $537 million response to the interim report of...
Empagliflozin for reducing risk of kidney stones
Research shows this SLGT2 inhibitor may reduce stones in people with diabetes, though how is unclear.
Kidney stones (urolithiasis) are commonly seen in primary care,...
Three in four pharmacies register with My Health Record
Almost a third of My Health Record-connected pharmacies have already reported using the system to avoid a potentially adverse event, according to new data...
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
